image256 – Photo Credit: Remedium Life Sciences of Georgia

The Northwest Georgia Joint Development Authority (NWGJDA) says that the partnership between the Town of Trion, Chattooga County, the NWGJDA and Remedium Life Sciences of Georgia could spur additional economic development and industry as plans move forward for Remedium to build a low-THC oil producing facility in Trion.

“Georgia’s Hope Act” created a safe and effective medical cannabis program for qualified patients in Georgia. The act established the Georgia Medical Cannabis Commission to oversee the program and authorized the commission to award six licenses to companies for in-state cultivation and manufacturing of low-THC oil. Included in this legislation was language encouraging companies to select Tier 1 and Tier 2 counties for their facility locations.

Jeff Mullis, who serves as the state senator for Georgia’s 53rd District and as the CEO of the NWGJDA says, “The Town of Trion, Chattooga County and Northwest Georgia are fortunate to be involved in the application process, having partnered with Remedium Life Science of Georgia. In fact, Chattooga County is one of only three Tier 1 counties north of I-20 and prior to COVID-19 reported the highest unemployment rate in the state at 12.2%.”

Mullis points out the significance of an economic development project of this size in a rural community that is expected to produce an initial 50 jobs.  Mullis says that Remedium has already donated over $200,000 to local families and the company has agreed to a profit-share arrangement with the Town of Trion and Chattooga County which could generate up to $1 million annually to support education and public health programs throughout the community.

According to Remedium’s website the company will be, “Utilizing cutting-edge technology and equipment in our state-of-the-art facility, will allow us to produce safe and effective treatments with efficiency while ensuring access to patients statewide. We specialize in researching and developing broad spectrum to indication specific treatments and partner with physicians and patients to deliver unique results.”